The European Commission had an ongoing open public consultation on ‘strengthened cooperation against vaccine-preventable diseases’ which ran until 15 March 2018. The objective of this consultation was to collect the views and input of citizens, administrations, associations and other relevant organisations to feed into the process of drafting a proposal for a Council Recommendation to be adopted in mid-2018.

The meeting focused on the evidence base for the revision of the updated “Guide to public health measures to reduce the impact of influenza pandemics in Europe”, with a specific emphasis on non-pharmaceutical countermeasures for pandemic flu.

On 3 October 2011 European Centre for Disease Prevention and Control (ECDC) and representatives of the European Vaccine Manufacturers  met at ECDC in Stockholm for a regular scheduled meeting about the use of vaccines for prevention of seasonal and pandemic influenza. ECDC Director Marc Sprenger opened the meeting and ECDC influenza experts held different presentations, such as burden of influenza disease in the EU, risk groups for severe influenza disease, personal protective measures, pandemic influenza preparedness, seasonal influenza vaccines, communication.
The Declarations of Interest for ECDC Influenza Staff and the ECDC Director are available here under ECDC Transparency.

ECDC training programme workshop on “Development of public health programmes for prevention and control of seasonal influenza” took place in Stockholm 8-10 October 2012.

ECDC organised a meeting among invited experts to exchange cross-disciplinary perspectives on the issue of MMR vaccination refusal among the general European population. ​

​The Week of Annual Meetings of European Tuberculosis Network was a joint effort of ECDC and its international partners to bring together European TB experts to discuss the common goal of eliminating TB in Europe.

The workshop aimed to explore new and more effective ways to promote influenza vaccination in healthcare professionals.

The aim of this side event was to develop and support effective country and regional responses to further improve the current HIV and tuberculosis situations and reduce their impacts on human lives, economy and society.

The International Liver Congress focused i.a. on PGC on Viral Hepatitis

The congress featured speakers from among the world’s leading experts in the field